中国卫生产业
中國衛生產業
중국위생산업
China Health Industry
2015年
17期
133-135
,共3页
门诊%静脉输注%抗菌药物%不良反应
門診%靜脈輸註%抗菌藥物%不良反應
문진%정맥수주%항균약물%불량반응
Department of outpatient%Intravenous injection%Antibacterial drug%Adverse drug reaction
目的 总结分析该院门诊静脉输注抗菌药物所致的不良反应资料,探讨可能原因及防范措施,促进合理用药.方法 对该院2014年12月-2015年4月门诊因静脉输注抗菌药物出现的13例不良反应记录进行统计分析. 结果13例不良反应记录中,女性与男性比例为1.17:1,多发于26~40岁,集中于β-内酰胺类与喹诺酮类抗生素,其中心血管反应5例(38.46%),皮肤及其附件4例(30.77%),12例经门诊救治后缓解,1例留院观察.结论 及时总结分析抗菌药物所致的不良反应,有利于加强抗菌药物的合理应用和细节管理,提高门诊的整体医疗水平.
目的 總結分析該院門診靜脈輸註抗菌藥物所緻的不良反應資料,探討可能原因及防範措施,促進閤理用藥.方法 對該院2014年12月-2015年4月門診因靜脈輸註抗菌藥物齣現的13例不良反應記錄進行統計分析. 結果13例不良反應記錄中,女性與男性比例為1.17:1,多髮于26~40歲,集中于β-內酰胺類與喹諾酮類抗生素,其中心血管反應5例(38.46%),皮膚及其附件4例(30.77%),12例經門診救治後緩解,1例留院觀察.結論 及時總結分析抗菌藥物所緻的不良反應,有利于加彊抗菌藥物的閤理應用和細節管理,提高門診的整體醫療水平.
목적 총결분석해원문진정맥수주항균약물소치적불량반응자료,탐토가능원인급방범조시,촉진합리용약.방법 대해원2014년12월-2015년4월문진인정맥수주항균약물출현적13례불량반응기록진행통계분석. 결과13례불량반응기록중,녀성여남성비례위1.17:1,다발우26~40세,집중우β-내선알류여규낙동류항생소,기중심혈관반응5례(38.46%),피부급기부건4례(30.77%),12례경문진구치후완해,1례류원관찰.결론 급시총결분석항균약물소치적불량반응,유리우가강항균약물적합리응용화세절관리,제고문진적정체의료수평.
Objective To summarize the adverse drug reaction of antibacterial drug administrated by intravenous injection in our hospital's department of outpatient, investigate the probable reason and the preventive methods, and promote the ra-tional use of drugs. Methods Collect 13 cases of adverse drug reaction data of antibacterial drug in our hospital's depart-ment of outpatient from Dec. 2014 to April. 2015 and analyze it statistically. Results Of all the adverse drug reaction, the ratio of men to women is 1:1.17, mainly occurred from 26 to 40 years, and often resulted by beta-lactams and quinolones antibacterial drugs. In the 13 cases of adverse reaction, 5 cases are cardiovascular system reaction (38.46%), 4 cases are skin reaction (30.77%), 12 cases relieved after rescue and treatment, and 1 case had to be in hospital. Conclusion Timely summary analysis of antimicrobial drug-induced adverse reactions, will help strengthen the rational use of antimicrobial a-gents and the details of management, improve the overall level of medical clinics.
